Canada: Supervision by Pharmacists Required for Sale of Nicotine Pouches and Similar Products
According to an announcement on the Canadian government's official website on August 22nd, Canadian Health Minister Mark Holland has introduced new measures regarding Nicotine Replacement Therapy (NRT) products in order to address the harm they pose to young people and to ensure that these products are only used by adults looking to quit smoking.
The new measures include:
- Prohibit advertising or promotion, including labels and packaging that may appeal to teenagers;
- Require new and emerging forms of nicotine replacement therapy (NRTs), such as nicotine pouches, to be sold only by pharmacists or individuals under pharmacist supervision, and must be placed behind the pharmacy counter;
- Ban the sale of emerging forms of nicotine replacement therapy, such as nicotine pouches, in flavors other than mint or menthol;
- Require nicotine addiction warnings to be prominently displayed on the packaging and clearly indicate its use as a smoking cessation aid for adults trying to quit smoking;
- Mandate manufacturers to submit samples of all new or revised nicotine replacement therapy license labels and packaging to ensure they do not appeal to teenagers.
According to Canada's Food and Drugs Act, NRT falls under the regulation of pharmaceutical products. All NRT products must obtain approval from Health Canada and be accompanied by an approved health claim in order to be legally sold in Canada.
The minister stated that...
Our primary goal is to protect the health and safety of Canadians, especially young Canadians. We know that smoking cessation products play an important role in helping adults quit smoking, but we need to ensure that these products are able to fulfill their intended purpose. Our action today is aimed at achieving this, while also protecting youth and non-smokers from the harmful effects of nicotine.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
